AXSM:NASDAQ, Axsome Therapeutics, Inc.
AXSM stock overview
Axsome Therapeutics, Inc. (AXSM:NASDAQ) closed at $132.37 on November 6, 2026,
up 1.98% on the day.
The stock trades 49.1% below its 52-week high of $260.19
and 7.6% above its 52-week low of $123.00.
Over the past year, it lost 4.2%.
Axsome Therapeutics, Inc. is part of the Health Care sector (Major Pharmaceuticals).
Key figures
- Price
- $132.37
- Day change
- +1.98%
- Volume
- 718,345
- Average volume
- 846,209
- Market cap
- 6B+
- 52-week range
- $123.00 – $260.19
- 50-day average
- $179.09
- 200-day average
- $198.41
Price action over the past year
In 252 trading sessions since November 6, 2025, AXSM closed higher on 114 days (45%).
Its best day was December 31, 2025 (+22.75%) and its worst was July 31, 2026 (-7.10%).
The stock moved 10% or more in a single session 2 times.
Recent signals
AXSM news
-
Nov 7, 2026:
Is Axsome Therapeutics (AXSM) Fully Priced Given Its Sales Growth?
-
Nov 6, 2026:
Axsome Therapeutics (AXSM) Stock Gets Fair Value Trim After Q3 Analyst Revisions
-
Nov 5, 2026:
Axsome Therapeutics vs. BioNTech: Which Healthcare Stock Is a Better Buy for 2027?
-
Nov 4, 2026:
Axsome: 3 Key Takeaways for Long-Term Investors
-
Nov 3, 2026:
AXSM Stock Has Slumped Nearly 20% Over The Past Month, But BofA Sees Selloff As Overdone
-
Nov 3, 2026:
Axsome Therapeutics Could Achieve Earnings in 2027 Amid Growing Auvelity Revenue, RBC Says
-
Nov 3, 2026:
Axsome Therapeutics to Participate in Upcoming Investor Conferences
-
Nov 3, 2026:
Revenue Growth And Narrower Losses Could Change The Case For Axsome Therapeutics Stock
About Axsome Therapeutics, Inc.
Axsome Therapeutics Inc is a pharmaceutical company in the United States. It focusses on developing novel therapeutics for the redressal of diseases related to the central nervous system.
Similar stocks
Find more stocks like AXSM with the
Spikes,
Gaps,
Breakouts and
Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.